文献速递类风湿关节炎

类风湿关节炎炎症加重时血脂与亚临床心肌损伤标志物出现分离

Divergence of Cardiovascular Biomarkers of Lipids and Subclinical Myocardial Injury Among Rheumatoid Arthritis Patients With Increased Inflammation.
PubMed 文献 · Arthritis Rheumatol · 2021-05-09

该纵向队列纳入196例类风湿关节炎患者,按hsCRP变化≥10 mg/L分为炎症升高组(n=103)与降低组(n=93)。炎症升高组平均hsCRP升高36 mg/L,伴随LDL胆固醇、甘油三酯、总胆固醇、Apo B和Apo A-I显著下降,而可检测hs-cTnT比例从基线45.6%进一步升高(P=0.02);炎症降低组hs-cTnT保持稳定。

要点

  • RA炎症升高时常规血脂指标下降,但亚临床心肌损伤标志物hs-cTnT升高。
  • 炎症升高组基线45.6%可检测hs-cTnT,炎症加重时进一步增加(P=0.02)。
  • 两队列中hs-cTnT均与总体估计CVD风险相关。

核心结论

  • RA患者炎症升高时常规血脂显著下降而亚临床心肌损伤标志物升高,提示CVD风险标志物出现分离。

研究设计与样本

  • 前瞻性纵向RA队列,共196例,每年测量血样和hsCRP。
  • 按任意间隔1年的两次时间点hsCRP变化≥10 mg/L分为炎症升高组(n=103)和炎症降低组(n=93)。

主要发现

  • 炎症升高组平均年龄59岁、81%为女性、平均RA病程17.9年,平均hsCRP升高36 mg/L。
  • 炎症升高组LDL胆固醇、甘油三酯、总胆固醇、Apo B和Apo A-I显著下降。
  • 炎症升高组基线45.6%(47/103)可检测循环hs-cTnT,炎症期间进一步增加(P=0.02)。
  • 炎症降低组随访期间尽管炎症下降,hs-cTnT保持稳定。
  • 两队列中hs-cTnT水平均与总体估计CVD风险相关。

临床怎么用

  • RA炎症加重时不应仅凭血脂下降判断CVD风险降低,需关注hs-cTnT等心肌损伤标志物。
  • 未来研究可评估将hs-cTnT纳入RA的CVD风险分层。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Patients with rheumatoid arthritis (RA) are 1.5 times more likely to develop cardiovascular disease (CVD) attributed to chronic inflammation. A decrease in inflammation in patients with RA is associated with increased low-density lipoprotein (LDL) cholesterol. This study was undertaken to prospectively evaluate the changes in lipid levels among RA patients experiencing changes in inflammation and determine the association with concomitant temporal patterns in markers of myocardial injury. METHODS: A total of 196 patients were evaluated in a longitudinal RA cohort, with blood samples and high-sensitivity C-reactive protein (hsCRP) levels measured annually. Patients were stratified based on whether they experienced either a significant increase in inflammation (an increase in hsCRP of ≥10 mg/liter between any 2 time points 1 year apart; designated the increased inflammation cohort [n = 103]) or decrease in inflammation (a decrease in hsCRP of ≥10 mg/liter between any 2 time points 1 year apart; designated the decreased inflammation cohort [n = 93]). Routine and advanced lipids, markers of inflammation (interleukin-6, hsCRP, soluble tumor necrosis factor receptor II), and markers of subclinical myocardial injury (high-sensitivity cardiac troponin T [hs-cTnT], N-terminal pro-brain natriuretic peptide) were measured. RESULTS: Among the patients in the increased inflammation cohort, the mean age was 59 years, 81% were women, and the mean RA disease duration was 17.9 years. The average increase in hsCRP levels was 36 mg/liter, and this increase was associated with significant reductions in LDL cholesterol, triglycerides, total cholesterol, apolipoprotein (Apo B), and Apo A-I levels. In the increased inflammation cohort at baseline, 45.6% of patients (47 of 103) had detectable circulating hs-cTnT, which further increased during inflammation (P = 0.02). In the decreased inflammation cohort, hs-cTnT levels remained stable despite a reduction in inflammation over follow-up. In both cohorts, hs-cTnT levels were associated with the overall estimated risk of CVD. CONCLUSION: Among RA patients who experienced an increase in inflammation, a significant decrease in routinely measured lipids, including LDL cholesterol, and an increase in markers of subclinical myocardial injury were observed. These findings highlight the divergence in biomarkers of CVD risk and suggest a role in future studies examining the benefit of including hs-cTnT for CVD risk stratification in RA.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Weber B, He Z, Yang N, et al. Divergence of Cardiovascular Biomarkers of Lipids and Subclinical Myocardial Injury Among Rheumatoid Arthritis Patients With Increased Inflammation. Arthritis Rheumatol. 2021. PMID: 33615723. doi:10.1002/art.41613

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。